Pfizer tops estimates, raises profit guidance even as sales fall ⊕⊕
Pfizer hiked its full-year profit guidance, citing its strong business performance and cost cuts, even as sales for the period fell.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.